The global mergers and acquisitions (M&A) landscape continues to witness robust activity across diverse sectors. In 2024, dealmakers are racing to close strategic transactions, secure synergistic opportunities, and respond to rapidly changing economic conditions. Recent transactions highlight how corporations and private equity firms are leveraging M&A to fuel growth, enter new markets, and consolidate their competitive advantages.

Keurig Dr Pepper Makes a Transformative Play with JDE Peet’s

One of the most significant deals in the latest cycle involves Keurig Dr Pepper (KDP), a top North American beverage conglomerate, acquiring Dutch coffee giant JDE Peet’s in a deal valued at approximately $18 billion. This acquisition, one of the largest consumer goods deals in recent years, significantly expands KDP’s international footprint and positions it as a global powerhouse in both hot and cold beverages.

JDE Peet’s brings with it a leading global coffee portfolio, including stalwart brands like Jacobs, Douwe Egberts, Peet’s Coffee, and L’OR. As consumer tastes evolve and coffee demand remains resilient worldwide, consolidation in the sector is intensifying. According to Statista, the global coffee market is projected to surpass $145 billion in value by 2025. The combined entity of KDP and JDE Peet’s will be uniquely positioned to capture growth in North America, Europe, and Asia-Pacific.

The deal also comes as beverage companies invest heavily in premium and ready-to-drink offerings and seek economies of scale to offset inflationary pressure on input costs. The transaction is expected to deliver meaningful synergies through supply chain integration, cross-selling opportunities, and innovation in product lines. Analysts suggest the move could set off a new wave of consolidation in the global beverage sector, as competitors reassess strategic priorities.

Private Equity’s Continued Expansion: Thoma Bravo Buys Verint for $2B

Private equity remains a powerful force in the M&A markets. In a notable technology sector move, Thoma Bravo, a leading tech-focused private equity firm with over $120 billion in assets under management, is acquiring Verint Systems for $2 billion. Verint specializes in customer engagement solutions and analytics powered by artificial intelligence—a segment experiencing rapid growth as digital transformation accelerates worldwide.

The deal highlights the sustained appetite among private equity firms for tech and software businesses with recurring revenues and mission-critical solutions. According to PwC’s Global M&A Industry Trends, technology, media, and telecommunications (TMT) deals accounted for 39% of overall M&A value in 2023, and 2024 shows no sign of slowing down. Thoma Bravo’s acquisition aims to help Verint scale up AI-powered offerings and expand its global client base by leveraging additional capital and operational expertise.

This deal follows a string of high-profile private equity transactions in 2024, such as Silver Lake’s bid for Qualtrics and Blackstone’s expansion in healthcare data. With global PE “dry powder” estimated at over $2 trillion, further M&A activity remains likely throughout the year.

Healthcare and Life Sciences Stay Active as Strategic Buyers Seek Growth

The healthcare and life sciences sector continues to see dynamic M&A, both from pharmaceutical firms and device manufacturers. Among the latest wave of deals:

• AbbVie announced its planned buyout of Gilgamesh Pharmaceuticals’ depression program for up to $1.2 billion—a move to bolster its neuroscience portfolio amid increasing mental health awareness and demand for innovative therapies.
• MannKind will acquire scPharmaceuticals in a $360 million deal aimed at expanding its cardiometabolic treatment options, reflecting the industry’s pursuit of next-generation treatments for chronic health conditions.
• Terumo is purchasing OrganOx for $1.5 billion, marking Terumo’s entry into liver transplant technology and highlighting a broader trend of medtech firms targeting specialty technologies via acquisition.

Healthcare M&A is expected to remain high in 2024, driven by patent cliffs, increased R&D costs, and the need to diversify revenue streams. EY forecasts global healthcare M&A value to grow, especially with interest in biotechnology and digital health targets.

Other Deal Highlights and Market Dynamics

• Crescent Energy is set to acquire Vital Energy in an all-stock deal valued at $3.1 billion, underlining continued consolidation among North American energy producers as firms seek operational efficiency and greater scale.
• FactSet, a premier financial data firm, is rumored as a potential takeover target, especially for private equity, as data analytics platforms become ever more central to capital markets activity.
• The Pinault family is reportedly weighing divestment or sale options for Puma, the German sportswear brand, reflecting shifting priorities among family-owned conglomerates amid changing global consumer dynamics.

Meanwhile, some high-profile deals have been withdrawn or are facing activist pressure, underscoring the volatility and complexity of today’s negotiation landscape. A notable example is Ki Corporation and Public Storage withdrawing their offer for Abacus Storage King, highlighting how regulatory scrutiny and valuation gaps can disrupt deal flow.

Trends Shaping 2024’s M&A Landscape

Several themes will define the M&A market for the rest of 2024:

• Cross-border transactions are rebounding, as corporations look beyond home markets to capture growth and hedge geopolitical risks.
• The role of private equity is expanding, with more large, strategic buys, especially in technology, healthcare, and consumer products.
• ESG (Environmental, Social, and Governance) factors increasingly influence deal rationale, particularly in energy and consumer sectors.
• A volatile interest rate environment remains a challenge for financing larger transactions, but creative deal structures, such as all-stock transactions or earn-outs, are on the rise.
• Continued regulatory scrutiny, especially in the U.S. and EU, may delay or alter some transformational deals as antitrust authorities apply closer oversight.

With macroeconomic headwinds and geopolitical uncertainty, dealmakers will need agility, due diligence, and innovative approaches to structure and close successful transactions.